智通财经APP获悉，金斯瑞生物科技(01548)午后跌幅扩大逾11%，截至发稿，跌11.07%，报13.41港元，成交额3.07亿港元。
消息面上，金斯瑞生物科技联营传奇生物隔夜股价大跌超7%，据媒体报道，在2025年美国血液学会（ASH）年会上，吉利德科学旗下 Kite Pharma 公布了下一代 CAR-T疗法 anito-cel 的最新临床数据。这款针对多发性骨髓瘤的候选药物展现出96%的总缓解率和 74% 的完全缓解率，同时保持优异安全性。
华泰证券此前研报指出，传奇生物亏损收窄，集团蓝图明晰。CARVYKTI前三季度实现销售额13.32亿美元，其中Q3销售额5.24亿美元；前三季度传奇生物实现净亏损2.66亿美元，其中Q3净亏损0.40亿美元，同比/环比均大幅减亏，看好金斯瑞生物科技各业务板块盈利有序增长/扭亏。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.